China (Mainland)
Premiumsupplier
- Product Details
Keywords
- Dacomitinib (PF299804)
- 99%Dacomitinib (PF299804)
- 1110813-31-4
Quick Details
- ProName: Dacomitinib (PF299804)
- CasNo: 1110813-31-4
- Molecular Formula: C24H25ClFN5O2
- Appearance: white solid
- Application: Dacomitinib (PF299804), which name is ...
- DeliveryTime: Within7-10 days after receipt of your ...
- PackAge: As customer request
- Port: Qingdao,China
- ProductionCapacity: 100 Kilogram/Week
- Purity: 99%
- Storage: room temp
- Transportation: By Sea/Air/Courier
- LimitNum: 10 Gram
Superiority
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Details
Dacomitinib (PF299804)
| CAS: | 1110813-31-4 |
| MF: | C24H25ClFN5O2 |
| MW: | 469.9390032 |
| Appearance: | White solid |
| Assay: | 99% |
| Boiling point: | 665.7±55.0 °C(Predicted) |
| desnity: | 1.344 |
| Uses: |
Dacomitinib is a selective and irreversible inhibitor of EGFR. It is a drug candidate for the treatment of non-small cell lung carcinoma. PF299804 is a potent, irreversible pan-ErbB inhibitor against ErbB1, ErbB2 and ErbB4 with IC50 of 6 nM, 45.7 nM and 73.7 nM, respectively. |
